MedTrace Logo

Intervention Trial in Early Age-related Macular Degeneration

NCT01694680 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2016-09-21

No results posted yet for this study

Summary

The purpose of the I-TEAM project is to assess whether there is a change in visual function and status of the retina after a year of intervention in subjects with early signs of Age-related Macular Degeneration.

Conditions

  • Age-related Macular Degeneration (AMD)

Interventions

DIETARY_SUPPLEMENT

Lutein-enriched-egg beverage (NWT-02)

Lutein, zeaxanthin and DHA-enriched-egg yolk combined with buttermilk beverage

DIETARY_SUPPLEMENT

Placebo

color-, taste- and energy-matched powder without enriched egg-yolk

Sponsors & Collaborators

  • Sprim Advanced Life Sciences

    collaborator OTHER

  • Newtricious R&D BV

    lead INDUSTRY

Principal Investigators

  • E J Johnson, PhD · Jean Mayer USDA Human Nutrition Research Center on Aging (HNRCA), Boston

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2016-04-30
Completion
2016-04-30

Countries

  • United States
  • Germany
  • Netherlands
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01694680 on ClinicalTrials.gov